| Mid-south Physical Therapy, Inc. | |
|
340 Atoka Mclaughlin Dr Ste B, Atoka, TN 38004-4825 | |
| (901) 837-1711 | |
| (901) 837-1232 |
| Full Name | Mid-south Physical Therapy, Inc. |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 340 Atoka Mclaughlin Dr Ste B, Atoka, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801985528 | NPI | - | NPPES |
| 3646013 | Medicaid | TN | |
| 3651450 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2580 (Tennessee) | Secondary |
| 225100000X | Physical Therapist | 569 (Tennessee) | Secondary |
| 225100000X | Physical Therapist | 7559 (Tennessee) | Primary |
| Provider Name | Michelle L Duncan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1972777357 PECOS PAC ID: 7911056247 Enrollment ID: I20090515000574 |
News Archive
Minority children die after surgery at higher rates than white children regardless of socioeconomic status (SES), according to a first-of-its-kind study being presented at the ANESTHESIOLOGY® 2021 annual meeting.
Research into how the brain transmits messages to other parts of the body could improve understanding of disorders such as epilepsy, dementia, multiple sclerosis and stroke.
New UBC research into brain cancer suggests treatments should target the cells around a tumor to stop it from spreading.
Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk. Over the past two years, Adimab has established collaborations with multiple leading pharmaceutical companies, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and now Biogen Idec and Novo Nordisk.
› Verified 1 days ago
| Provider Name | Michael J Majestic |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952647018 PECOS PAC ID: 0749422699 Enrollment ID: I20130806000636 |
News Archive
Minority children die after surgery at higher rates than white children regardless of socioeconomic status (SES), according to a first-of-its-kind study being presented at the ANESTHESIOLOGY® 2021 annual meeting.
Research into how the brain transmits messages to other parts of the body could improve understanding of disorders such as epilepsy, dementia, multiple sclerosis and stroke.
New UBC research into brain cancer suggests treatments should target the cells around a tumor to stop it from spreading.
Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk. Over the past two years, Adimab has established collaborations with multiple leading pharmaceutical companies, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and now Biogen Idec and Novo Nordisk.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mid-south Physical Therapy, Inc. 340 Atoka Mclaughlin Dr Ste B, Atoka, TN 38004-4825 Ph: (901) 837-1711 | Mid-south Physical Therapy, Inc. 340 Atoka Mclaughlin Dr Ste B, Atoka, TN 38004-4825 Ph: (901) 837-1711 |
News Archive
Minority children die after surgery at higher rates than white children regardless of socioeconomic status (SES), according to a first-of-its-kind study being presented at the ANESTHESIOLOGY® 2021 annual meeting.
Research into how the brain transmits messages to other parts of the body could improve understanding of disorders such as epilepsy, dementia, multiple sclerosis and stroke.
New UBC research into brain cancer suggests treatments should target the cells around a tumor to stop it from spreading.
Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk. Over the past two years, Adimab has established collaborations with multiple leading pharmaceutical companies, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and now Biogen Idec and Novo Nordisk.
› Verified 1 days ago
Dr. Danielle Nicole Spencer, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 11680 Highway 51 S Ste A-1, Atoka, TN 38004 Phone: 901-837-0994 Fax: 901-837-0999 | |
Bradley Langley, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10992 Highway 51 S, Suite 100, Atoka, TN 38004 Phone: 901-837-1711 | |
Mcmahon Physical Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10992 Highway 51 S Ste 100, Atoka, TN 38004 Phone: 901-486-9064 | |
Encompass Health Partners Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10992 Highway 51 S, Suite 100, Atoka, TN 38004 Phone: 901-601-7996 Fax: 901-837-1232 | |
Dr. Milfred Olin Eckel Iii, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10992 Highway 51 S, Suite 100, Atoka, TN 38004 Phone: 901-837-1711 Fax: 901-837-1232 | |
Dr. Kenneth Phillip Mcmahon, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 10992 Highway 51 S Ste 100, Atoka, TN 38004 Phone: 901-486-9064 | |
Dawn B Caldwell, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10992 Highway 51 S, Suite 100, Atoka, TN 38004 Phone: 901-837-1711 Fax: 901-837-1232 |